SCHEMBL4847499

SCHEMBL4847499

COc1ccc([N+](=O)[O-])cc1CC(=O)O

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.60
CYP1A2 P05177 1/20 0.59
ALDH1A1 P00352 4/20 0.57
TDP1 Q9NUW8 1/20 0.54
AMY1A P0DUB6 1/20 0.54
LMNA P02545 3/20 0.53
GAA P10253 2/20 0.53
HPGD P15428 1/20 0.53
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
HTT P42858 4/20 0.51
MAPT P10636 2/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
PKM P14618 1/20 0.50
APOBEC3A P31941 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4364148 1.00 HSD17B10 (0.60) HSD17B10CYP1A2ALDH1A1TDP1AMY1A
SCHEMBL29812478 0.88 CYP1A2 (0.63) CYP1A2ALDH1A1TDP1AMY1ALMNA
SCHEMBL1626559 0.88 CYP1A2 (0.63) CYP1A2ALDH1A1TDP1AMY1ALMNA
SCHEMBL9156278 0.87 ALDH1A1 (0.58) CYP1A2ALDH1A1TDP1LMNAGAA
SCHEMBL6922213 0.85 ALDH1A1 (0.55) ALDH1A1TDP1LMNAGAAHPGD
SCHEMBL7633475 0.85 GAA (0.54) ALDH1A1TDP1LMNAGAAHPGD
SCHEMBL27376292 0.85 CYP1A2 (0.59) HSD17B10CYP1A2ALDH1A1TDP1AMY1A
SCHEMBL4364949 0.84 ALDH1A1 (0.53) ALDH1A1TDP1LMNAGAAHPGD
SCHEMBL2191038 0.83 ALDH1A1 (0.56) CYP1A2ALDH1A1TDP1LMNAGAA
SCHEMBL215804 0.83 TDP1 (0.58) CYP1A2ALDH1A1TDP1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3128838-B1 PLANT STIMULATORS, USE THEREOF AND METHOD OF PLANT STIMULATION AGRA GROUP AS (CZ) 2020-04-29 EP disclosed
EP-3128838-A1 PLANT STIMULATORS, USE THEREOF AND METHOD OF PLANT STIMULATION Agra Group, A.S. (CZ) 2017-02-15 EP disclosed
WO-2015154732-A1 PLANT STIMULATORS, USE THEREOF AND METHOD OF PLANT STIMULATION AGRA GROUP A.S. (CZ) 2015-10-15 WO disclosed
EP-1606268-B1 5,10-DIHYDRO-11H-DIBENZO[B,E][1,4]DIAZEPIN-11-ONE AS KINASE INHIBITORS ABBVIE INC (US) 2015-05-20 EP disclosed
US-7456169-B2 Heterocyclic kinase inhibitors ABBOTT LABORATORIES INC. (US) 2008-11-25 US disclosed
US-20070254867-A1 Heterocyclic Kinase Inhibitors ABBVIE INC. 2007-11-01 US disclosed
US-20040254159-A1 Heterocyclic kinase inhibitors ABBOTT LABORATORIES 2004-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254159-A1 Heterocyclic kinase inhibitors MAP3K20, MAP3K19, MAP3K1 HSD17B10 1906/4885CYP1A2 2785/4885ALDH1A1 2391/4885
US-20070254867-A1 Heterocyclic Kinase Inhibitors MAP3K20, MAP3K19, MAP4K2 HSD17B10 2543/4885CYP1A2 3589/4885ALDH1A1 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.